Johnson & Johnson reported a 4.9 percent year-on-year increase in Q2 sales to $1,241 million for its Vision business unit, which includes both contact lenses and surgery activities. In constant currencies, revenue went up by 10.9 percent versus Q2 2021.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.